Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect.
Blankenship K, Burns L, Scharf M. Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect. Cutis. 2022 Sep; 110(3):E19-E20.
View in:
PubMed
subject areas
Acne Vulgaris
Antibodies, Monoclonal, Humanized
Humans
authors with profiles
Mark J Scharf MD